Identification of Clinical and Bacterial Genetic Risk Factors Associated with Klebsiella Pneumoniae Infection

Total Page:16

File Type:pdf, Size:1020Kb

Identification of Clinical and Bacterial Genetic Risk Factors Associated with Klebsiella Pneumoniae Infection Identification of Clinical and Bacterial Genetic Risk Factors Associated with Klebsiella pneumoniae Infection by Rebekah Michal Martin A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Molecular and Cellular Pathology) in the University of Michigan 2017 Doctoral Committee: Assistant Professor Michael A. Bachman, Chair Professor Nicholas W. Lukacs Professor Harry L.T. Mobley Professor Gabriel Núñez Assistant Professor Evan S. Snitkin Rebekah Michal Martin [email protected] ORCID iD: 0000-0001-9729-0283 © Rebekah Michal Martin 2017 DEDICATION To my grandfathers: George Bernard Skidmore, who gifted me my first microscope & Robert James Martin, who believed I would achieve great things ii ACKNOWLEDGEMENTS I owe a deep debt of appreciation to several people for their assistance, guidance, and support throughout this journey. Without each and every one of them, this journey would have looked quite different. My advisor, Mike, deserves my utmost gratitude. He allowed me to pursue a complicated, fascinating project despite my limited experience in this field of research and with practically all the methods we used. Because of him, I have increased my critical thinking skills and developed into a more accomplished scientist, writer, and communicator. His impact will stay with me as I progress in my career, and I will look to him as an example of what a successful mentor should be. Being a trainee in his lab provided the best graduate experience I could have asked for. I am also appreciative to the many individuals who passed through the Bachman lab during my time there, and the ways in which they impacted me professionally. I would be remiss if I did not thank those who had a hand in preparing me for graduate school ̶ even before I knew this was the path I wished to pursue. To the Michigan State University Biomedical Laboratory Diagnostics Program (BLD) faculty, staff and students: this program and faculty are what sparked my interest in teaching. I am thankful for the passion they imparted for learning about diseases and disease processes, and the continued support and encouragement they provide in every facet of my life. BLD will always be home to me. To the Clinical Microbiology directors & medical lab scientists of Henry Ford Hospital (HFH): this is where I fell in love with clinical microbiology and with being part of the patient care team. This experience helped frame my current career aspirations, and HFH will always be full of family to me. Special thanks are iii owed to Robert Tibbetts & Linoj Samuel who continue to answer my many questions and to help me navigate the field of clinical microbiology. I am also indebted to the many other individuals who mentored me in various ways throughout graduate school: my committee, Gary Huffnagle, Nick Lukacs, Harry Mobley, Gabriel Núñez, and Evan Snitkin who provided continual advice and assistance. I am truly honored to have each of them on my committee and impacting my project. Maria Sandkvist and Lynne Shetron- Rama for their guidance and advice on how to be an effective university instructor. Duane Newton for allowing me to take up space in the University of Michigan Clinical Microbiology Lab, and for taking the time to provide career advice and share his journey. I have been fortunate to have a fantastic group of friends, both from graduate school and from other stages of my life: the MCP and PIBS students, who provided much needed stress relief through trivia nights, movie and game nights, and sharing in day-to-day struggles and adventures. My best friend Marie Tyrrell, who has been my sounding board and encouragement from afar. My family have supported my passion for science since before I can remember, and have been a constant source of encouragement through each milestone and each setback. My parents have reminded me of everything I am capable of and that they support me whatever comes. My sister, Elisa, was my first hero & role model and continues to be a source of support even from across the ocean. Without my husband and partner, Ben Dettmar, this journey undoubtedly would have never happened. I still remember the moment he told me I was capable of pursuing a graduate degree, and from that moment I never looked back. He has always encouraged me to fulfill my potential, and he has taught me to slow down and embrace life along the way. I am forever grateful for the iv support, encouragement, & advice he still provides daily. I cannot imagine this life adventure with anyone else x. v TABLE OF CONTENTS DEDICATION………………………………………………………………………………….ii ACKNOWLEDGEMENTS…………………………………………………………………...iii LIST OF TABLES……………………………………………………………………………viii LIST OF FIGURES…………………………………………………………………………....ix LIST OF ACRONYMS AND ABBREVIATIONS……………………………………...…...xi ABSTRACT……………………………………………………………………………………..1 CHAPTER I: Introduction……………………………………………………………………..3 1.1 Introduction………………………………………………………………………4 1.2 Klebsiella pneumoniae: an opportunistic, hospital-acquired infection…………..5 1.3 Emergence of antibiotic resistance in Klebsiella pneumoniae…………………13 1.4 Community-acquired hypervirulent strains…………………………………….18 1.5 Klebsiella species are distinguished by their accessory genome…………….....20 1.6 Gaps in knowledge……………………………………………………………...22 1.7 Conclusions……………………………………………………………………..23 1.8 Outline of thesis………………………………………………………………...23 CHAPTER II: Molecular Epidemiology of Colonizing and Infecting Klebsiella pneumoniae Clinical Isolates………………………………………………25 2.1 Introduction…………………………………………………………………….26 2.2 Results………………………………………………………………………….28 2.3 Discussion……………………………………………………………………...48 vi 2.4 Experimental procedures……………………………………………………....51 2.5 Notes…………………………………………………………………………...56 CHAPTER III: Identification of Pathogenicity-Associated Loci in Klebsiella pneumoniae Clinical Isolates………………………………………………………………………..57 3.1 Introduction…………………………………………………………………….58 3.2 Results………………………………………………………………………….60 3.3 Discussion…………………………………………………………………….103 3.4 Experimental procedures……………………………………………………..108 3.5 Notes………………………………………………………………………….116 CHAPTER IV: Discussion…………………………………………………………………..117 4.1 Summary of thesis……………………………………………………………117 4.2 Host factors contribute to epidemiology of infection………………………...118 4.3 Identifying at-risk patients may help guide empiric therapy………...…….…120 4.4 Identifying colonization may aid in infection prevention…………………….121 4.5 Identification and characterization of pathogenicity-associated loci……....…124 4.6 Species misidentification may impact clinical care…………………………..125 4.7 Clinical modeling and bacterial whole genome sequencing in clinical care…126 4.8 Conclusions…………………………………………………………………...128 REFERENCES……………………………………………………………………………….131 vii LIST OF TABLES Table 2.1: Demographic characteristics of patients with and without infection ………..……….30 Table 2.2: Prior colonization with K. pneumoniae vs. subsequent infection……………..……...32 Table 2.3: Association with prior colonization for each site of infection…………………...…...33 Table 2.4: Multiple logistic regression model of risk factors for infection…………..……….…35 Table 2.5: Categorical agreement of colonizing-infecting isolate pairs in case patients……...…47 Table 3.1: Clinical characteristics of cases and controls…………………………………..…….62 Table 3.2: Multivariable model for clinical infection with K. pneumoniae…………………..…63 Table 3.3: Gene alignment counts…………………………………………………………...…..68 Table 3.4: Genes present in significantly different frequencies between cases and controls……75 Table 3.5: Bacterial genes significantly and independently associated with clinical infection….78 Table 3.6: Multivariable model of factors predictive for patient infection…………………...….81 Table 3.7: Variant analysis of WT and mutant strains……………………...…………………..100 Table 3.8: Multivariable model for psicose metabolism locus association with infection……..102 viii LIST OF FIGURES Figure 2.1: Study population……………………………………………………………………..29 Figure 2.2: Receiver operator characteristic curve for multivariable model of risk factors for clinical infection………………………………………………………………………….36 Figure 2.3: wzi sequencing method has similar discriminatory power to MLST…….…….……38 Figure 2.4: Phylogenetic tree for wzi sequence of patient rectal swab isolates……………...…..39 Figure 2.5: Phylogenetic trees of rectal swab and infecting isolates based on wzi gene sequencing………………………………………………………………………………..41 Figure 2.6: Core genome similarity between infecting and colonizing strains within patients….43 Figure 2.7: Concordant colonizing-infecting isolate pairs show high core genome allelic similarity…………………………………………………………………………………45 Figure 3.1: Receiver operator characteristic curve for a multivariable model of factors predictive for patient infection………………………………………………………………………64 Figure 3.2: Pathogenicity-associated locus sequencing (PAL-Seq)………………………….….66 Figure 3.3: Phylogenetic tree of Kp phylogroups………………………...…………………...…70 Figure 3.4: Hierarchical clustering of accessory genes………………………………...…….….72 Figure 3.5: Principal component analysis of normalized count sum data…………………...…..73 Figure 3.6: Pathogenicity-associated loci (PALs)…………………………………..………...…79 Figure 3.7: Phylogenetic analysis of clinical isolates……………………………..………….….83 Figure 3.8: Deletion of terC does not affect growth in nutrient rich broth………………………86 Figure 3.9: Deletion of terC confers a tellurite sensitive phenotype………………...…………..87 ix Figure 3.10: Competitive index of terC mutant compared to WT……………………………....88 Figure 3.11: Deletion of KP1_RS12820
Recommended publications
  • 516278V1.Full.Pdf
    bioRxiv preprint doi: https://doi.org/10.1101/516278; this version posted January 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 1 Description of Klebsiella africanensis sp. nov., 2 Klebsiella variicola subsp. tropicalensis subsp. nov. 3 and Klebsiella variicola subsp. variicola subsp. nov. 4 5 Carla Rodriguesa†, Virginie Passeta†, Andriniaina Rakotondrasoab, Thierno Abdoulaye 6 Dialloc, Alexis Criscuolod & Sylvain Brissea,* 7 8 a Institut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France 9 b Institut Pasteur Madagascar, Antananarivo, Madagascar 10 c Institut Pasteur of Dakar, Senegal 11 d Institut Pasteur, Bioinformatics and Biostatistics Hub, C3BI, USR 3756 IP CNRS, Paris, 12 France. 13 14 † These authors contributed equally to this work. 15 16 E-mail addresses: [email protected] (C. Rodrigues), 17 [email protected] (V. Passet), [email protected] (A. Rakotondrasoa), 18 [email protected] (T. A. Diallo), [email protected] (A. Criscuolo), 19 [email protected] (S. Brisse) “*Correspondence and reprints” 20 bioRxiv preprint doi: https://doi.org/10.1101/516278; this version posted January 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 2 21 Abstract 22 The bacterial pathogen Klebsiella pneumoniae comprises several phylogenetic groups 23 (Kp1 to Kp7), two of which (Kp5 and Kp7) have no taxonomic status. Here we show that 24 group Kp5 is closely related to Klebsiella variicola (Kp3), with an average nucleotide identity 25 (ANI) of 96.4%, and that group Kp7 has an ANI of 94.7% with Kp1 (K.
    [Show full text]
  • Treatment of Carbapenem-Resistant Klebsiella Pneumoniae
    Review For reprint orders, please contact [email protected] Review Treatment of Expert Review of Anti-infective Therapy carbapenem-resistant © 2013 Expert Reviews Ltd Klebsiella pneumoniae: 10.1586/ERI.12.162 the state of the art 1478-7210 Expert Rev. Anti Infect. Ther. 11(2), 159–177 (2013) 1744-8336 Nicola Petrosillo1, The increasing incidence of carbapenem-resistant Klebsiella pneumoniae (CR-KP) fundamentally Maddalena alters the management of patients at risk to be colonized or infected by such microorganisms. Giannella*1, Russell Owing to the limitation in efficacy and potential for toxicity of the alternative agents, many Lewis2 and Pierluigi experts recommend using combination therapy instead of monotherapy in CR-KP-infected 2 patients. However, in the absence of well-designed comparative studies, the best combination Viale for each infection type, the continued role for carbapenems in combination therapy and when 12nd Division of Infectious Diseases, combination therapy should be started remain open questions. Herein, the authors revise current National Institute for Infectious Diseases microbiological and clinical evidences supporting combination therapy for CR-KP infections to ‘Lazzaro Spallanzani’, Rome, Italy 2Department of Medical & Surgical address some of these issues. Sciences – Alma Mater Studiorum, University of Bologna, Bologna, Italy KEYWORDS: carbapenem-resistant Klebsiella pneumoniae s CARBAPENEMASE PRODUCING STRAINS s COMBINATION *Author for correspondence: antimicrobial therapy Tel.: +39 065 517 0499 Fax: +39 065 517 0486 Life-threatening infections caused by multidrug- levofloxacin and imipenem (IMP) in vitro [8,9]. [email protected] resistant (MDR) and sometimes pan-resistant Yet, no clinical studies on combination ther- Gram-negative bacteria have increased dramati- apy in Gram-negative infections to date have cally in the last decade [1] .
    [Show full text]
  • Klebsiella Pneumoniae Ar-Bank#0453
    KLEBSIELLA PNEUMONIAE AR-BANK#0453 Key RESISTANCE: KPC MIC (µg/ml) RESULTS AND INTERPRETATION PROPAGATION DRUG MIC INT DRUG MIC INT MEDIUM Amikacin 32 I Colistin 0.5 --- Ampicillin >32 R Doripenem >8 R Medium: Trypticase Soy Agar with 5% Sheep Blood (BAP) Ampicillin/sulbactam1 >32 R Ertapenem >8 R GROWTH CONDITIONS Aztreonam >64 R Gentamicin 1 S Temperature: 35⁰C Cefazolin >8 R Imipenem >64 R Atmosphere: Aerobic 2 Cefepime >32 R Imipenem+chelators >32 --- PROPAGATION Levofloxacin PROCEDURE Cefotaxime >64 R >8 R Cefotaxime/clavulanic 1 >32 --- Meropenem >8 R Remove the sample vial to a acid container with dry ice or a Cefoxitin >16 R Piperacillin/tazobactam1 >128 R freezer block. Keep vial on ice Ceftazidime >128 R Polymyxin B 0.5 --- or block. (Do not let vial content thaw) Ceftazidime/avibactam1 16 R3 Tetracycline 8 I Ceftazidime/clavulanic >64 --- Tigecycline 1 S3 Open vial aseptically to avoid acid1 contamination Ceftriaxone >32 R Tobramycin 16 R 1 Using a sterile loop, remove a Ciprofloxacin >8 R Trimethoprim/sulfamethoxazole >8 R small amount of frozen isolate from the top of the vial S – I –R Interpretation (INT) derived from CLSI 2016 M100 S26 1 Reflects MIC of first component Aseptically transfer the loop 2 Screen for metallo-beta-lactamase production to BAP [Rasheed et al. Emerging Infectious Diseases. 2013. 19(6):870-878] 3 Based on FDA break points Use streak plate method to isolate single colonies Incubate inverted plate at 35⁰C for 18-24 hrs. [email protected] http://www.cdc.gov/drugresistance/resistance-bank/ BIOSAFETY LEVEL 2 Appropriate safety procedures should always be used with this material.
    [Show full text]
  • Klebsiella Pneumoniae: Virulence, Biofilm and Antimicrobial Resistance
    Divya Bharathi PIDJ ESPID REPORTS AND REVIEWS PIDJ-217-384 CONTENTS Klebsiella pneumoniae Vitulence, Biofilm and Resistance in Klebsiella EDITORIAL BOARD Piperaki et al Editor: Delane Shingadia Board Members David Burgner (Melbourne, Cristiana Nascimento-Carvalho George Syrogiannopoulos XXX Australia) (Bahia, Brazil) (Larissa, Greece) Kow-Tong Chen (Tainan,Taiwan) Ville Peltola (Turku, Finland) Tobias Tenenbaum (Mannhein, Germany) Luisa Galli (Florence, Italy) Emmanuel Roilides (Thessaloniki, Marc Tebruegge (Southampton, UK) Steve Graham (Melbourne, Pediatr Infect Dis J Greece) Marceline Tutu van Furth (Amsterdam, Australia) Ira Shah (Mumbai, India) The Netherlands) Lippincott Williams & Wilkins Klebsiella pneumoniae: Virulence, Biofilm and Antimicrobial Hagerstown, MD Resistance Evangelia-Theophano Piperaki, MD, PhD,* George A. Syrogiannopoulos, MD, PhD,† Leonidas S. Tzouvelekis, MD, PhD,* and George L. Daikos, MD, PhD‡ Key Words: Klebsiella pneumoniae, virulence, ingitis in premature neonates and infants as the immune response through cytokine and biofilm, resistance well as serious infections in immunocompro- chemokine production (Fig. 1). Among the mised and malnourished children, whereas effector cells that are recruited first to the in the community, K. pneumoniae is a com- infection site are the neutrophils. Impor- mon cause of urinary tract infections among tant mediators involved in this process are lebsiella pneumoniae is a ubiquitous immunocompetent children. interleukin (IL)-8 and IL-23, which induces K Gram-negative encapsulated bacterium In recent years, most K. pneumoniae production of IL-17 that promotes granu- that resides in the mucosal surfaces of mam- infections are caused by strains termed “clas- lopoietic response.6-7 IL-12 also amplifies the mals and the environment (soil, water, etc.). sic” K. pneumoniae (cKp).
    [Show full text]
  • Seasonal Variation in Klebsiella Pneumoniae Blood Stream Infection
    log bio y: O ro p c e i n M A l a c c c i e n s i l s Khan et al., Clin Microbiol 2016, 5:2 C Clinical Microbiology: Open Access 10.4172/2327-5073.1000247 ISSN: 2327-5073 DOI: Research Article Open Access Seasonal Variation in Klebsiella pneumoniae Blood Stream Infection: A Five Year Study Fatima Khan, Naushaba Siddiqui*, Asfia Sultan, Meher Rizvi, Indu Shukla and Haris M Khan Department of Microbiology, Jawaharlal Nehru Medical College and Hospital, AMU, Aligarh, India *Corresponding author: Naushaba Siddiqui, Department of Microbiology, Jawaharlal Nehru Medical College and Hospital, AMU, Aligarh, India, Tel: +919897520952; E- mail: [email protected] Received date: April 08, 2016; Accepted date: April 28, 2016; Published date: April 30, 2016 Copyright: © 2016 Khan F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Introduction: Klebsiella pneumoniae is a ubiquitous environmental organism and a common cause of serious gram-negative infections in humans. This study was conducted to examine the association between seasonal variation and the incidence rate of Klebsiella pneumoniae blood stream infection. Material and methods: The retrospective study was conducted in the Department of Microbiology, JN Medical College AMU Aligarh for a period of 5 years from January 2011 to December 2015. Samples were received for blood culture in brain heart infusion broth. Cultures showing growth of Klebsiella pneumoniae were identified using standard biochemical procedures.
    [Show full text]
  • Complete Genome Sequence of Endophytic Nitrogen-Fixing
    Lin et al. Standards in Genomic Sciences (2015) 10:22 DOI 10.1186/s40793-015-0004-2 SHORT GENOME REPORT Open Access Complete genome sequence of endophytic nitrogen-fixing Klebsiella variicola strain DX120E Li Lin1†, Chunyan Wei2†, Mingyue Chen3†, Hongcheng Wang3, Yuanyuan Li3, Yangrui Li1,2, Litao Yang1,2,4* and Qianli An3* Abstract Klebsiella variicola strain DX120E (=CGMCC 1.14935) is an endophytic nitrogen-fixing bacterium isolated from sugarcane crops grown in Guangxi, China and promotes sugarcane growth. Here we summarize the features of the strain DX120E and describe its complete genome sequence. The genome contains one circular chromosome and two plasmids, and contains 5,718,434 nucleotides with 57.1% GC content, 5,172 protein-coding genes, 25 rRNA genes, 87 tRNA genes, 7 ncRNA genes, 25 pseudo genes, and 2 CRISPR repeats. Keywords: Endophyte, Klebsiella variicola, Klebsiella pneumoniae, Nitrogen fixation, Pathogenicity, Plant growth-promoting bacteria, Sugarcane Introduction roots and shoots, to fix N2 in association with sugarcane The species Klebsiella variicola was classified in 2004 plants, and to promote sugarcane growth [10], and and consisted of clinical and plant-associated isolates thusshowsapotentialasabiofertilizer.Herewe [1].The species K. singaporensis was classified in 2004 present a summary of the features of the K. variicola based on a single soil isolate [2] and was recently identi- strain DX120E (=CGMCC 1.14935) and its complete fied as a later junior heterotypic synonym of K. variicola genome sequence, and thus provide a genetic back- [3]. K. variicola is able to fix N2 [1]. K. variicola strain ground to understand its endophytic lifestyle, plant At-22, one of the dominant bacteria in the fungus gar- growth-promoting potentials, and similarities and dens of leaf-cutter ants, provides nitrogen source by N2 differences to other plant-associated and clinical K.
    [Show full text]
  • Melioidosis: Misdiagnosed in Nepal
    Shrestha et al. BMC Infectious Diseases (2019) 19:176 https://doi.org/10.1186/s12879-019-3793-x CASEREPORT Open Access Melioidosis: misdiagnosed in Nepal Neha Shrestha1* , Mahesh Adhikari1, Vivek Pant2, Suman Baral3, Anjan Shrestha4, Buddha Basnyat5, Sangita Sharma1 and Jeevan Bahadur Sherchand1 Abstract Background: Melioidosis is a life-threatening infectious disease that is caused by gram negative bacteria Burkholderia pseudomallei. This bacteria occurs as an environmental saprophyte typically in endemic regions of south-east Asia and northern Australia. Therefore, patients with melioidosis are at high risk of being misdiagnosed and/or under-diagnosed in South Asia. Case presentation: Here, we report two cases of melioidosis from Nepal. Both of them were diabetic male who presented themselves with fever, multiple abscesses and developed sepsis. They were treated with multiple antimicrobial agents including antitubercular drugs before being correctly diagnosed as melioidosis. Consistent with this, both patients were farmer by occupation and also reported travelling to Malaysia in the past. The diagnosis was made consequent to the isolation of B. pseudomallei from pus samples. Accordingly, they were managed with intravenous meropenem followed by oral doxycycline and cotrimoxazole. Conclusion: The case reports raise serious concern over the existing unawareness of melioidosis in Nepal. Both of the cases were left undiagnosed for a long time. Therefore, clinicians need to keep a high index of suspicion while encountering similar cases. Especially diabetic-farmers who present with fever and sepsis and do not respond to antibiotics easily may turn out to be yet another case of melioidosis. Ascertaining the travel history and occupational history is of utmost significance.
    [Show full text]
  • Targeting the Burkholderia Cepacia Complex
    viruses Review Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex Philip Lauman and Jonathan J. Dennis * Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-780-492-2529 Abstract: The increasing prevalence and worldwide distribution of multidrug-resistant bacterial pathogens is an imminent danger to public health and threatens virtually all aspects of modern medicine. Particularly concerning, yet insufficiently addressed, are the members of the Burkholderia cepacia complex (Bcc), a group of at least twenty opportunistic, hospital-transmitted, and notoriously drug-resistant species, which infect and cause morbidity in patients who are immunocompromised and those afflicted with chronic illnesses, including cystic fibrosis (CF) and chronic granulomatous disease (CGD). One potential solution to the antimicrobial resistance crisis is phage therapy—the use of phages for the treatment of bacterial infections. Although phage therapy has a long and somewhat checkered history, an impressive volume of modern research has been amassed in the past decades to show that when applied through specific, scientifically supported treatment strategies, phage therapy is highly efficacious and is a promising avenue against drug-resistant and difficult-to-treat pathogens, such as the Bcc. In this review, we discuss the clinical significance of the Bcc, the advantages of phage therapy, and the theoretical and clinical advancements made in phage therapy in general over the past decades, and apply these concepts specifically to the nascent, but growing and rapidly developing, field of Bcc phage therapy. Keywords: Burkholderia cepacia complex (Bcc); bacteria; pathogenesis; antibiotic resistance; bacterio- phages; phages; phage therapy; phage therapy treatment strategies; Bcc phage therapy Citation: Lauman, P.; Dennis, J.J.
    [Show full text]
  • Isolation, Characterization and Prevention of Various Microbial Strains in NIC Unit and PIC Unit M
    www.nature.com/scientificreports OPEN Isolation, characterization and prevention of various microbial strains in NIC unit and PIC unit M. Amin Mir1*, Muhammad Waqar Ashraf1, Vibha Tripathi2 & Bilal Ahmad Mir2 The health of the hospital associated persons, particularly those dealing directly with insertion of devices, are serious cause of concern for hospitals. In this study, the most prevalent organism on the surface of medical devices in PICU were CoNS (16.66%) and Staphylococcus aureus (16.66%), while in NICU the most prevalent organism was Klebsiella spp. (11.25%) among Entero-bacteriaceae group followed by Acinetobacter baumannii (10%), Escherichia coli (2.5%), CoNS (6.25%), S. aureus (6.25%) and Enterococcus faecalis (6.25%). The most common species identifed from blood specimen of clinical samples shows the maximum presence of Candida sp. (60/135) followed by A. baumannii (21/135), Klebsiella Pneumoniae (20/135), Enterococci (12/135), Burkholderia cepacia complex (8/135), S. aureus (6/135), E. coli (5/135), Pseudomonas aeruginosa (3/135). Diferent antibiotics have been used against these micro-organisms; but Cotrimoxazole, Vancomycin have been found more efective against CoNS bacteria, Clindamycin, Tetracycline for S. aureus, Nitofurantoin for Acinetobacter, and for E. faecalis, A. baumanii, and Klebsiella, erythromycin, Colistin, and Ceftriaxone have been found more efective respectively. Te infections (HCAIs/HAIs) of the health care associates are indicators of the out comings of poor quality of patient care. Te Infections of the health-care set-ups have direct adverse Consequence, which afect the patients, their families, visitors and society as well. Te control of infection of HAIs is therefore the need of an hour.
    [Show full text]
  • A Klebsiella Variicola Plasmid Confers Hypermucoviscosity-Like Phenotype and Alters Capsule Production and Virulence
    fmicb-11-579612 December 11, 2020 Time: 17:56 # 1 ORIGINAL RESEARCH published: 16 December 2020 doi: 10.3389/fmicb.2020.579612 A Klebsiella variicola Plasmid Confers Hypermucoviscosity-Like Phenotype and Alters Capsule Production and Virulence Edited by: Nadia Rodríguez-Medina1,2, Esperanza Martínez-Romero3, Miguel Angel De la Cruz4, Axel Cloeckaert, Miguel Angel Ares4, Humberto Valdovinos-Torres5, Jesús Silva-Sánchez1, Institut National de Recherche pour Luis Lozano-Aguirre6, Jesús Martínez-Barnetche5, Veronica Andrade7 and l’agriculture, l’alimentation et Ulises Garza-Ramos1* l’environnement (INRAE), France Reviewed by: 1 Laboratorio de Resistencia Bacteriana, Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional Kwan Soo Ko, de Salud Pública, Cuernavaca, Mexico, 2 Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma Sungkyunkwan University School of de México, México City, Mexico, 3 Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Medicine, South Korea Mexico, 4 Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Hospital de Pediatría, Centro Médico Marcelo Tolmasky, Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico, 5 Departamento de Inmunología, Instituto California State University, Fullerton, Nacional de Salud Pública, CISEI, Cuernavaca, Mexico, 6 Centro de Ciencias Genómicas, Laboratorio de Genómica United States Evolutiva, Universidad Nacional Autónoma de México, Cuernavaca, Mexico, 7 Hospital Regional Centenario de la Revolución Ying Shun Zhou, Mexicana, ISSSTE, Emiliano Zapata, Mexico Southwest Medical University, China Séamus Fanning, University College Dublin, Ireland Hypermucoviscosity (hmv) is a capsule-associated phenotype usually linked with *Correspondence: hypervirulent Klebsiella pneumoniae strains. The key components of this phenotype are Ulises Garza-Ramos the RmpADC proteins contained in non-transmissible plasmids identified and studied [email protected] in K.
    [Show full text]
  • How Are Gene Sequence Analyses Modifying Bacterial Taxonomy? the Case of Klebsiella
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Hemeroteca Cientifica Catalana REVIEW ARTICLE INTERNATIONAL MICROBIOLOGY (2004) 7:261-268 www.im.microbios.org Julio Martínez1 How are gene sequence Lucía Martínez1,2 Mónica Rosenblueth1 analyses modifying Jesús Silva3 Esperanza Martínez-Romero1* bacterial taxonomy? The case of Klebsiella 1 Genomic Science Center, National University of México (UNAM), Cuernavaca, Mexico 2Research Center of Biological Summary. Bacterial names are continually being changed in order to and Medical Sciences, Faculty of Medicine more adequately describe natural groups (the units of microbial diversity) and Surgery, Autonomous University and their relationships. The problems in Klebsiella taxonomy are illustra- Benito Juárez, Oaxaca, Mexico tive and common to other bacterial genera. Like other bacteria, Klebsiella 3National Institute of Public Health, spp. were isolated long ago, when methods to identify and classify bacte- Cuernavaca, Mexico ria were limited. However, recently developed molecular approaches have led to taxonomical revisions in several cases or to sound proposals of novel species. [Int Microbiol 2004; 7(4):261-268] Received 30 September 2004 Accepted 20 October 2004 Key words: Klebsiella · Enterobacteria · pathogenic bacteria · species *Corresponding author: concept · bacterial taxonomy · phylogeny E. Martínez-Romero Centro de Ciencias Genómicas, UNAM Apdo. Postal 565-A Cuernavaca, Morelos, México Tel. 52-7773131697. Fax 52-7773135581 E-mail: [email protected] which ammonium is produced from gaseous dinitrogen. Introduction Klebsiella variicola may also serve as a model to define a bacterial species (see below). Although Klebsiella species are Historically, the classification of Klebsiella species, like that widely distributed in water, soil, and plants as well as in of many other bacteria, was based on their pathogenic fea- sewage water, it is the human pathogens that have rendered tures or origin.
    [Show full text]
  • Nosocomial Infections by Klebsiella Pneumoniae Carbapenemase Producing Enterobacteria in a Teaching Hospital
    ORIGINAL ARTICLE Nosocomial infections by Klebsiella pneumoniae carbapenemase producing enterobacteria in a teaching hospital Infecções hospitalares por enterobactérias produtoras de Klebsiella pneumoniae carbapenemase em um hospital escola Gabriela Seibert1, Rosmari Hörner1, Bettina Holzschuh Meneghetti1, Roselene Alves Righi1, Nara Lucia Frasson Dal Forno1, Adenilde Salla1 ABSTRACT Métodos: Estudo retrospectivo descritivo. A partir do isolamento Objective: To analyze the profile of patients with microorganisms em exames bacteriológicos solicitados pelos clínicos, descrevemos resistant to carbapenems, and the prevalence of the enzyme as características clínicas e epidemiológicas dos pacientes que Klebsiella pneumoniae carbapenemase in interobacteriaceae. Methods: apresentaram enterobactérias resistentes aos carbapenêmicos entre Retrospective descriptive study. From the isolation in bacteriological março e outubro de 2013 em um hospital universitário. Resultados: tests ordered by clinicians, we described the clinical and epidemiological Foram incluídos 47 pacientes isolados, todos apresentando resistência characteristics of patients with enterobacteria resistants to carbapenems aos carbapenêmicos, dos quais 9 tiveram confirmação de infecção/ at a university hospital, between March and October 2013. Results: colonização por K. pneumoniae carbapenemase. Ocorreu predomínio We included 47 isolated patients in this study, all exhibiting resistance de isolamento em aspirados traqueais (12; 25,5%). A resistência ao to carbapenems, including 9 patients who were confirmed as infected/ ertapenem, meropenem e imipenem foi de 91,5%, 83,0% e 80,0%, colonized with K. pneumoniae carbapenemase. Isolation in tracheal respectivamente. Os aminoglicosídeos foram a classe de antimicrobianos aspirates (12; 25.5%) predominated. The resistance to ertapenem, que apresentou maior sensibilidade, sendo 91,5% sensível a amicacina meropenem, and imipenem was 91.5%, 83.0% and 80.0%, respectively.
    [Show full text]